Tech Company Financing Transactions
Quench Bio Funding Round
Quench Bio, based in Cambridge, raised $50 million from RA Capital, AbbVie Biotech Ventures and Arix Bioscience.
Transaction Overview
Company Name
Announced On
1/28/2020
Transaction Type
Venture Equity
Amount
$50,000,000
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
400 Technology Sq. 10th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Undisclosed
Website
Email Address
Overview
At Quench Bio we are discovering inhibitors of novel targets in innate immunity, the gasdermins. A central player in multiple pathways leading to inflammatory cell death, Gasdermin D acts as the executioner of pyroptosis and NETosis.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Samantha Truex
Chief Scientific Officer
Iain Kilty
Chief Technical Officer
Mark Tebbe
Browse more venture capital transactions:
Prev: 1/28/2020: AmazeVR venture capital transaction
Next: 1/28/2020: SuperAwesome venture capital transaction
Share this article
Where The Data Comes From
We do our best to document tech company VC transactions. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs